# Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

> **NCT01850368** · PHASE2 · COMPLETED · sponsor: **Korea Cancer Center Hospital** · enrollment: 35 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombus

## Interventions

- **RADIATION:** Stereotactic ablative radiotherapy

## Key facts

- **NCT ID:** NCT01850368
- **Lead sponsor:** Korea Cancer Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-07
- **Final completion:** 2017-07
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850368, "Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01850368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*